Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Urology
|
November 20, 2013
Editorial comment
Elizabeth A Handorf, Marc C Smaldone
JAMA Surgery
|
June 30, 2018
Bladder Extirpation vs Preservation: The Treatment Debate
David B Cahn, Elizabeth A Handorf, Marc C Smaldone
Biometrical Journal. Biometrische Zeitschrift
|
December 21, 2022
Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods
Elizabeth A Handorf, Marc C Smaldone, Sujana Movva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 15, 2016
Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis
Adam J Friedant, Elizabeth A Handorf, Stacey Su, et al.
American Journal of Preventive Medicine
|
December 21, 2012
Breast cancer risk prediction and mammography biopsy decisions: a model-based study
Katrina Armstrong, Elizabeth A Handorf, Jinbo Chen, et al.
Statistical Methods in Medical Research
|
February 23, 2018
Estimating cost-effectiveness from claims and registry data with measured and unmeasured confounders
Elizabeth A Handorf, Daniel F Heitjan, Justin E Bekelman, et al.
Cancer
|
February 4, 2020
Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men
Shannon M Lynch, Kristen Sorice, Erin K Tagai, et al.
JNCI Cancer Spectrum
|
September 23, 2022
Assessing Oncologists' Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data
Pritish Iyer, Mengying Deng, Elizabeth A Handorf, et al.
The Annals of Applied Statistics
|
March 4, 2014
EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT
Elizabeth A Handorf, Justin E Bekelman, Daniel F Heitjan, et al.
The Oncologist
|
May 13, 2022
Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data
James M Martin, Elizabeth A Handorf, Alberto J Montero, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Urology
|
November 20, 2013
Editorial comment
Elizabeth A Handorf, Marc C Smaldone
JAMA Surgery
|
June 30, 2018
Bladder Extirpation vs Preservation: The Treatment Debate
David B Cahn, Elizabeth A Handorf, Marc C Smaldone
Biometrical Journal. Biometrische Zeitschrift
|
December 21, 2022
Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods
Elizabeth A Handorf, Marc C Smaldone, Sujana Movva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 15, 2016
Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis
Adam J Friedant, Elizabeth A Handorf, Stacey Su, et al.
American Journal of Preventive Medicine
|
December 21, 2012
Breast cancer risk prediction and mammography biopsy decisions: a model-based study
Katrina Armstrong, Elizabeth A Handorf, Jinbo Chen, et al.
Statistical Methods in Medical Research
|
February 23, 2018
Estimating cost-effectiveness from claims and registry data with measured and unmeasured confounders
Elizabeth A Handorf, Daniel F Heitjan, Justin E Bekelman, et al.
Cancer
|
February 4, 2020
Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men
Shannon M Lynch, Kristen Sorice, Erin K Tagai, et al.
JNCI Cancer Spectrum
|
September 23, 2022
Assessing Oncologists' Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data
Pritish Iyer, Mengying Deng, Elizabeth A Handorf, et al.
The Annals of Applied Statistics
|
March 4, 2014
EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT
Elizabeth A Handorf, Justin E Bekelman, Daniel F Heitjan, et al.
The Oncologist
|
May 13, 2022
Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data
James M Martin, Elizabeth A Handorf, Alberto J Montero, et al.
Page
of 9